公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 QIAGEN BIOTECNOLOGIA BRASIL LTDA.取消

74 记录

产品持有公司班级有效性
QIAsymphony DSP Virus/Pathogen Kit10322250046QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QUIMIOLUMINÔMETRO DML 2000 DIGENE SISTEMA LUMINÔMETRO EM MICROPLACA10322250012QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
QuantiFERON CMV 2 Plate Kit ELISA10322250081QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV26/02/2028
QuantiFERON Monitor ELisa10322250078QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
QuantiFERON Monitor LyoSphere10322250079QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
QuantiFERON Monitor Tubos10322250076QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QuantiFERON-TB Gold Blood Collection Tubes10322250049QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QuantiFERON®-TB GOLD Plus (QFT® Plus)10322250071QIAGEN BIOTECNOLOGIA BRASIL LTDA.III05/09/2036
RAPID CAPTURE SYSTEM10322259002QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
RNeasy DSP FFPE Kit10322250088QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
ROTARY SHAKER10322259007QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
Reagentes PyroMark Gold Q2410322250045QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
Rotor-Gene Q MDx 5plex10322250129QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
Rotor-Gene Q MDx 5plex HRM10322250128QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
Rotor-Gene Q MDx 6plex10322250127QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
artus BK Virus QS-RGQ10322250074QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
artus CMV QS-RGQ kit10322250084QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV04/06/2028
artus CT/NG QS RGQ Kit10322250075QIAGEN BIOTECNOLOGIA BRASIL LTDA.III20/02/2027
artus HSV 1/2 QS RGQ10322250080QIAGEN BIOTECNOLOGIA BRASIL LTDA.III02/01/2028
ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit10322250096QIAGEN BIOTECNOLOGIA BRASIL LTDA.III15/06/2030
ipsogen JAK2 RGQ PCR Kit10322250099QIAGEN BIOTECNOLOGIA BRASIL LTDA.III14/12/2030
ipsogen® CALR RGQ PCR Kit10322250120QIAGEN BIOTECNOLOGIA BRASIL LTDA.III08/05/2033
therascreen EGFR RGQ PCR kit v310322250132QIAGEN BIOTECNOLOGIA BRASIL LTDA.III02/09/2034
therascreen PIK3CA RGQ PCR Kit10322250098QIAGEN BIOTECNOLOGIA BRASIL LTDA.III30/11/2030

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家